ATP-sensitive potassium channels: A promising target for protecting neurovascular unit function in stroke

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 2, 2010, Pages 243-252

  Sun, Xiu Lan ^a   Hu, Gang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

ATP sensitive potassium channels; Neurovascular unit; Stroke

Indexed keywords

4 AMINOBUTYRIC ACID; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ADENOSINE TRIPHOSPHATASE (POTASSIUM); BMS 191095; DIAZOXIDE; EXCITATORY AMINO ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; NEUROPROTECTIVE AGENT; PINACIDIL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL CYCLE PROGRESSION; CENTRAL NERVOUS SYSTEM; DNA SYNTHESIS; DRUG EFFICACY; HUMAN; INSULIN RELEASE; MICROGLIA; MITOCHONDRIAL MEMBRANE; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; REVIEW; STROKE;

ANIMALS; ASTROCYTES; BRAIN; BRAIN ISCHEMIA; GAP JUNCTIONS; GLUTAMIC ACID; HUMANS; KATP CHANNELS; MICE; MICROGLIA; NEUROGENESIS; POTASSIUM CHANNELS; RATS; STROKE; VASODILATION;

EID: 75649145870     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05190.x     Document Type: Review

References (119)

1. Bushnell CD, Hurn P, Colton C et al. Advancing the study of stroke in women: Summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke 2006 37 : 2387 2399.
2. Green AR. Pharmacological approaches to acute ischaemic stroke: Reperfusion certainly, neuroprotection possibly. Br. J. Pharmacol. 2008 153 (Suppl. 1 S325 38.
3. Green AR, Shuaib A. Therapeutic strategies for the treatment of stroke. Drug Discov. Today 2006 11 : 681 693.
4. Zhao BQ, Tejima E, Lo EH. Neurovascular proteases in brain injury, hemorrhage and remodeling after stroke. Stroke 2007 38 : 748 752.
5. Montaner J. Stroke biomarkers: Can they help us to guide stroke thrombolysis? Drug News Perspect. 2006 19 : 523 532.
6. Liu D, Lu C, Wan R, Auyeung WW, Mattson MP. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J. Cereb. Blood Flow Metab. 2002 22 : 431 443.
7. Takahashi M, Macdonald RL. Vascular aspects of neuroprotection. Neurol. Res. 2004 26 : 862 869.
8. Hertz L, Peng L, Dienel GA. Energy metabolism in astrocytes: High rate of oxidative metabolism and spatiotemporal dependence on glycolysis/ glycogenolysis. J. Cereb. Blood Flow Metab. 2007 27 : 219 249.
9. Chuquet J, Hollender L, Nimchinsky EA. High-resolution in vivo imaging of the neurovascular unit during spreading depression. J. Neurosci. 2007 27 : 4036 4044.
10. Aarts M, Iihara K, Wei WL et al. A key role for TRPM7 channels in anoxic neuronal death. Cell 2003 115 : 863 877.
11. 2+ exchanger in excitotoxicity. Cell 2005 120 : 275 285.
12. Cao J, Viholainen JI, Dart C, Warwick HK, Leyland ML, Courtney MJ. The PSD95-nNOS interface: A target for inhibition of excitotoxic p38 stress-activated protein kinase activation and cell death. J. Cell Biol. 2005 168 : 117 126.
13. Han HS, Suk K. The function and integrity of the neurovascular unit rests upon the integration of the vascular and inflammatory cell systems. Curr. Neurovasc. Res. 2005 2 : 409 423.
14. Zlokovic BV. New therapeutic targets in the neurovascular pathway in Alzheimer's disease. Neurotherapeutics 2008 5 : 409 414.
15. Lo EH. Experimental models, neurovascular mechanisms and translational issues in stroke research. Br. J. Pharmacol. 2008 153 (Suppl. 1 S396 405.
16. Lok J, Gupta P, Guo S et al. Cell-cell signaling in the neurovascular unit. Neurochem. Res. 2007 32 : 2032 2045.
17. McCarty JH. Cell biology of the neurovascular unit: Implications for drug delivery across the blood-brain barrier. Assay Drug Dev. Technol. 2005 3 : 89 95.
18. Ishida T, Yarimizu K, Gute DC, Korthuis RJ. Mechanisms of ischemic preconditioning. Shock 1997 8 : 86 94.
19. + channels are redox-sensitive pathways that control reactive oxygen species production. Free Radic. Biol. Med. 2007 42 : 1039 1048.
20. Maneuf YP, Duty S, Hille CJ, Crossman AR, Brotchie JM. Modulation of GABA transmission by diazoxide and cromakalim in the globus pallidus: Implications for the treatment of Parkinson's disease. Exp. Neurol. 1996 139 : 12 16.
21. Watts AE, Hicks GA, Henderson G. Putative pre- and postsynaptic ATP-sensitive potassium channels in the rat substantia nigra in vitro. J. Neurosci. 1995 15 : 3065 3074.
22. + channels. Science 1990 247 : 852 854.
23. Stanford IM, Lacey MG. Electrophysiological investigation of adenosine trisphosphate-sensitive potassium channels in the rat substantia nigra pars reticulata. Neuroscience 1996 74 : 499 509.
24. ATP channel openers facilitate glutamate uptake by GluTs in rat primary cultured astrocytes. Neuropsychopharmacology 2008 33 : 1336 1342.
25. Bruun JM, Roeske-Nielsen A, Richelsen B, Fredman P, Buschard K. Sulfatide increases adiponectin and decreases TNF-alpha, IL-6, and IL-8 in human adipose tissue in vitro. Mol. Cell. Endocrinol. 2007 263 : 142 148.
26. Zhou F, Wu JY, Sun XL, Yao HH, Ding JH, Hu G. Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation. Neuropsychopharmacology 2007 32 : 2570 2580.
27. Kakei M, Noma A, Shibasaki T. Properties of adenosine-triphosphate- regulated potassium channels in guinea-pig ventricular cells. J. Physiol. 1985 363 : 441 462. (Pubitemid 15000318)
28. ATP channel-deficient pancreatic β-cells are streptozotocin resistant because of lower GLUT2 activity. Am. J. Physiol. Endocrinol. Metab. 2008 294 : E326 35.
29. + channel-mediated hypoxic preconditioning. Cardiovasc. Res. 2008 77 : 126 133.
30. ATP channel during induction of ischemic preconditioning in the rat hippocampus. Brain Res. 2007 1184 : 345 353.
31. Wan TC, Ge ZD, Tampo A et al. The A3 adenosine receptor agonist CP-532,903 [N6-(2,5-dichlorobenzyl)-3′-aminoadenosine-5′-N- methylcarboxamide] protects against myocardial ischemia/reperfusion injury via the sarcolemmal ATP-sensitive potassium channel. J. Pharmacol. Exp. Ther. 2008 324 : 234 243.
32. Elrod JW, Harrell M, Flagg TP et al. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury. Circulation 2008 117 : 1405 1413.
33. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am. J. Physiol. 1998 274 : C25 37.
34. + channels. Trends Neurosci. 1998 21 : 288 294.
35. ATP channels. J. Physiol. 2004 554 : 353 370.
36. + channel in rat cultured cortical neurons. Pflügers Arch. 1992 422 : 260 266.
37. Matsumoto N, Komiyama S, Akaike N. Pre- and postsynaptic ATP-sensitive potassium channels during metabolic inhibition of rat hippocampal CA1 neurons. J. Physiol. 2002 541 : 511 520.
38. Thomzig A, Laube G, Pruss H, Veh RW. Pore-forming subunits of K-ATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat braJ. Comp. Neurol. 2005 484 : 313 330.
39. Thomzig A, Wenzel M, Karschin C et al. Kir6.1 is the principal pore-forming subunit of astrocyte but not neuronal plasma membrane K-ATP channels. Mol. Cell. Neurosci. 2001 18 : 671 690.
40. Zhou F, Yao HH, Wu JY, Ding JH, Sun T, Hu G. Opening of microglial K channels inhibits rotenone-induced neuroinflammation. J. Cell. Mol. Med. 2008 12 : 1559 1570.
41. Zunkler BJ. Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects. Pharmacol. Ther. 2006 112 : 12 37.
42. + channels in cardiac muscle. Nature 1983 305 : 147 148.
43. + channels. Neuron 1996 16 : 1011 1017.
44. + channels in smooth muscle. J. Physiol. 2006 572 : 617 624.
45. +-channel, Kir6.2, in rat brain neurons and glial cells. Brain Res. Mol. Brain Res. 2002 101 : 23 32.
46. Sun HS, Feng ZP, Barber PA, Buchan AM, French RJ. Kir6.2-containing ATP-sensitive potassium channels protect cortical neurons from ischemic/anoxic injury in vitro and in vivo. Neuroscience 2007 144 : 1509 1515.
47. Peters A, Schweiger U, Fruhwald-Schultes B, Born J, Fehm HL. The neuroendocrine control of glucose allocation. Exp. ClEndocrinol. Diabetes 2002 110 : 199 211.
48. + ATP channel and protein kinase C. Neuroscience 1999 89 : 453 459.
49. + channels in cerebral ischemic preconditioning. Proc. Natl Acad. Sci. USA 1995 92 : 4666 4670.
50. Yamada K, Inagaki N. ATP-sensitive K(+) channels in the brain: Sensors of hypoxic conditions. News Physiol. Sci. 2002 17 : 127 130.
51. Tai KK, McCrossan ZA, Abbott GW. Activation of mitochondrial ATP-sensitive potassium channels increases cell viability against rotenone-induced cell death. J. Neurochem. 2003 84 : 1193 1200.
52. Busija DW, Lacza Z, Rajapakse N et al. Targeting mitochondrial ATP-sensitive potassium channels: A novel approach to neuroprotection. Brain Res. Brain Res. Rev. 2004 46 : 282 294.
53. Gidday JM, Shah AR, Maceren RG et al. Nitric oxide mediates cerebral ischemic tolerance in a neonatal rat model of hypoxic preconditioning. J. Cereb. Blood Flow Metab. 1999 19 : 331 340.
54. Marcoli M, Bonfanti A, Roccatagliata P et al. Glutamate efflux from human cerebrocortical slices during ischemia: Vesicular-like mode of glutamate release and sensitivity to A (2A) adenosine receptor blockade. Neuropharmacology 2004 47 : 884 891.
55. Erdo F, Berzsenyi P, Andrasi F. The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia. Brain Res. Bull. 2005 66 : 43 9.
56. Wang H, Zhang YL, Tang XC, Feng HS, Hu G. Targeting ischemic stroke with a novel opener of ATP-sensitive potassium channels in the braMol. Pharmacol. 2004 66 : 1160 1168.
57. Yang Y, Liu X, Ding JH et al. Effects of iptakalim on rotenone-induced cytotoxicity and dopamine release from PC12 cells. Neurosci. Lett. 2004 366 : 53 7.
58. + channels. J. Neurophysiol. 2006 95 : 2590 2601.
59. ATP channels. J. Mol. Cell. Cardiol. 2005 38 : 945 949.
60. Downey JM, Cohen MV. Do mitochondrial K(ATP) channels serve as triggers rather than end-effectors of ischemic preconditioning's protection? Basic Res. Cardiol. 2000 95 : 272 274.
61. Bajgar R, Seetharaman S, Kowaltowski AJ, Garlid KD, Paucek P. Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in braJ. Biol. Chem. 2001 276 : 33 369 74.
62. + channel in the braBrain Res. 2003 994 : 27 36.
63. Liu D, Lu C, Wan R, Auyeung WW, Mattson MP. Activation of mitochondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J. Cereb. Blood Flow Metab. 2002 22 : 431 443.
64. Kis B, Rajapakse NC, Snipes JA, Nagy K, Horiguchi T, Busija DW. Diazoxide induces delayed pre-conditioning in cultured rat cortical neurons. J. Neurochem. 2003 87 : 969 980.
65. Mayanagi K, Gaspar T, Katakam PV, Kis B, Busija DW. The mitochondrial K (ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 2007 27 : 348 355.
66. Wu L, Shen F, Lin L, Zhang X, Bruce IC, Xia Q. The neuroprotection conferred by activating the mitochondrial ATP-sensitive K(+) channel is mediated by inhibiting the mitochondrial permeability transition pore. Neurosci. Lett. 2006 402 : 184 189.
67. Koehler RC, Gebremedhin D, Harder DR. Role of astrocytes in cerebrovascular regulation. J. Appl. Physiol. 2006 100 : 307 317.
68. Kim JH, Kim JH, Park JA et al. Blood-neural barrier: Intercellular communication at glio-vascular interface. J. Biochem. Mol. Biol. 2006 39 : 339 345.
69. Kielian T. Glial connexins and gap junctions in CNS inflammation and disease. J. Neurochem. 2008 106 : 1000 1016.
70. Nakase T, Naus CC. Gap junctions and neurological disorders of the central nervous system. Biochim. Biophys. Acta 2004 1662 : 149 158.
71. Adermark L, Lovinger DM. Electrophysiological properties and gap junction coupling of striatal astrocytes. Neurochem. Int. 2008 52 : 1365 1372.
72. Figiel M, Allritz C, Lehmann C, Engele J. Gap junctional control of glial glutamate transporter expression. Mol. Cell. Neurosci. 2007 35 : 130 137.
73. Theis M, Sohl G, Eiberger J, Willecke K. Emerging complexities in identity and function of glial connexins. Trends Neurosci. 2005 28 : 188 195.
74. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: Redefining the functional architecture of the braTrends Neurosci. 2003 26 : 523 530.
75. Danbolt NC. Glutamate uptake. Prog. Neurobiol. 2001 65 : 1 105.
76. Nakase T, Fushiki S, Sohl G, Theis M, Willecke K, Naus CC. Neuroprotective role of astrocytic gap junctions in ischemic stroke. Cell Commun. Adhes. 2003 10 : 413 417.
77. 2+-independent mechanism. J. Neurochem. 2000 74 : 1249 1256.
78. 2+on gap junction permeability in cultured astrocytes. FEBS Lett. 1998 427 : 41 5.
79. Matute C, Domercq M, Sanchez-Gomez MV. Glutamate-mediated glial injury: Mechanisms and clinical importance. Glia 2006 53 : 212 224.
80. Schousboe A, Waagepetersen HS. Role of astrocytes in glutamate homeostasis: Implications for excitotoxicity. Neurotox. Res. 2005 8 : 221 225.
81. Ferrarese C, Begni B, Canevari C et al. Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ann. Neurol. 2000 47 : 641 643.
82. Madl JE, Burgesser K. Adenosine triphosphate depletion reverses sodium-dependent, neuronal uptake of glutamate in rat hippocampal slices. J. Neurosci. 1993 13 : 4429 4444.
83. Hamann M, Rossi DJ, Marie H, Attwell D. Knocking out the glial glutamate transporter GLT-1 reduces glutamate uptake but does not affect hippocampal glutamate dynamics in early simulated ischaemia. Eur. J. Neurosci. 2002 15 : 308 314.
84. Haydon PG, Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 2006 86 : 1009 1031.
85. Dienel GA, Cruz NF. Astrocyte activation in working brain: Energy supplied by minor substrates. Neurochem. Int. 2006 48 : 586 595.
86. Fellin T, Sul JY, D'Ascenzo M, Takano H, Pascual O, Haydon PG. Bidirectional astrocyte-neuron communication: The many roles of glutamate and ATP. Novartis Found. Symp. 2006 276 : 208 217.
87. Anderson CM, Swanson RA. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions. Glia 2000 32 : 1 14.
88. Wang S, Hu LF, Zhang Y et al. Effects of systemic administration of iptakalim on extracellular neurotransmitter levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats. Neuropsychopharmacology 2006 31 : 933 940.
89. Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: Mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 2003 304 : 1 7.
90. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog. Neurobiol. 2005 76 : 77 98.
91. Minghetti L. Role of inflammation in neurodegenerative diseases. Curr. OpNeurol. 2005 18 : 315 321.
92. Cagnin A, Kassiou M, Meikle SR, Banati RB. In vivo evidence for microglial activation in neurodegenerative dementia. Acta Neurol. Scand. Suppl. 2006 185 : 107 114.
93. Yang Y, Liu X, Long Y et al. Systematic administration of iptakalim, an ATP-sensitive potassium channel opener, prevents rotenone-induced motor and neurochemical alterations in rats. J. Neurosci. Res. 2005 80 : 442 449.
94. Yang Y, Liu X, Long Y et al. Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. Int. J. Neuropsychopharmacol. 2006 9 : 51 61.
95. Farkas E, Timmer NM, Domoki F, Mihaly A, Luiten PG, Bari F. Post-ischemic administration of diazoxide attenuates long-term microglial activation in the rat brain after permanent carotid artery occlusion. Neurosci. Lett. 2005 387 : 168 172.
96. Rougier A, Auvergne R. Adult brain neurogenesis and pathology. Neurochirurgie 2004 50 : 33 41.
97. Kelleher-Andersson J. Discovery of neurogenic, Alzheimer's disease therapeutics. Curr. Alzheimer Res. 2006 3 : 55 62.
98. Ong J, Plane JM, Parent JM, Silverstein FS. Hypoxic-ischemic injury stimulates subventricular zone proliferation and neurogenesis in the neonatal rat. Pediatr. Res. 2005 58 : 600 606.
99. ATP channels regulate mitogenically induced proliferation in primary rat hepatocytes and human liver cell lines. Implications for liver growth control and potential therapeutic targeting. J. Biol. Chem. 2000 275 : 26 050 7.
100. ATP channels: Effects on cell cycle progression in rodent islets. J. Biol. Chem. 2006 281 : 3261 3267.
101. ATP channel opener, in cultured rabbit pulmonary arterial smooth muscle cells. Eur. J. Pharmacol. 2005 511 : 81 7.
102. Moreau R, Komeichi H, Kirstetter P, Ohsuga M, Cailmail S, Lebrec D. Altered control of vascular tone by adenosine triphosphate-sensitive potassium channels in rats with cirrhosis. Gastroenterology 1994 106 : 1016 1023.
103. Wilson AJ, Clapp LH. The molecular site of action of K(ATP) channel inhibitors determines their ability to inhibit iNOS-mediated relaxation in rat aorta. Cardiovasc. Res. 2002 56 : 154 163.
104. Pearce WJ, Elliott SR. Maturation enhances the sensitivity of ovine cerebral arteries to the ATP-sensitive potassium channel activator lemakalim. Pediatr. Res. 1994 35 : 729 732.
105. Kwan AL, Lin CL, Howng SL. Attenuation of basilar artery spasm after experimental subarachnoid hemorrhage in rabbit by potassium channel activator cromakalim: A preliminary result. Kaohsiung J. Med. Sci. 1999 15 : 268 273 (in Chinese).
106. + channels in the vertebrobasilar system of the rabbit. Circ. Res. 1996 78 : 238 243.
107. + channel function in piglet cerebral arteries. Stroke 1997 28 : 2273 2279.
108. + channel function in cerebral arterioles in piglets. Stroke 1996 27 : 1874 1880.
109. Santa N, Kitazono T, Ago T et al. ATP-sensitive potassium channels mediate dilatation of basilar artery in response to intracellular acidification in vivo. Stroke 2003 34 : 1276 1280.
110. + ATP-channel activation causes marked vasodilation in the hypertensive neonatal pig lung. Am. J. Physiol. 1992 263 : H1532 6.
111. Toyoda K, Fujii K, Ibayashi S, Kitazono T, Nagao T, Fujishima M. Role of ATP-sensitive potassium channels in brain stem circulation during hypotension. Am. J. Physiol. 1997 273 : H1342 6.
112. 2+-activated potassium channels. J. Cereb. Blood Flow Metab. 2003 23 : 1227 1238.
113. Kawano H, Kawano T, Tanaka K, Eguchi S, Takahashi A, Nakaya Y, Oshita S. Effects of dopamine on ATP-sensitive potassium channels in porcine coronary artery smooth-muscle cells. J. Cardiovasc. Pharmacol. 2008 51 : 196 201.
114. Zhang H, Gu YT, Xue YX. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5′-triphosphate-sensitive potassium channel. Brain Res. 2007 1144 : 33 41. (Pubitemid 46440831)
115. Lenzser G, Kis B, Bari F, Busija DW. Diazoxide preconditioning attenuates global cerebral ischemia-induced blood-brain barrier permeability. Brain Res. 2005 1051 : 72 80.
116. Banks WA. Delivery of peptides to the brain: Emphasis on therapeutic development. Biopolymers 2008 90 : 589 594.
117. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: Structural components and function under physiologic and pathologic conditions. J. Neuroimmune Pharmacol. 2006 1 : 223 236.
118. + (ATP) channels in both normal and hypercholesterolemic rabbits. J. Cardiovasc. Pharmacol. 2007 49 : 287 292.
119. Masada T, Hua Y, Xi G, Ennis SR, Keep RF. Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat. J. Cereb. Blood Flow Metab. 2001 21 : 22 33.